Zusammenfassung
Bei Patienten mit Nierenfunktionseinschränkung treten schlafbezogene Atemstörungen signifikant häufiger auf, im Vergleich mit Nierengesunden mit gleichen Risikofaktoren ist das Risiko für obstruktive Schlafapnoe bei terminaler Niereninsuffizienz vierfach erhöht. Die typischen Symptome Tagesmüdigkeit oder -schläfrigkeit werden bei Nierenpatienten häufig der Anämie oder Urämie zugeschrieben. Dies erklärt wahrscheinlich, warum die Schlafapnoe bisher bei diesem Kollektiv noch zu selten diagnostiziert wird. Niereninsuffizienz und Schlafapnoe haben gemeinsame pathophysiologische Angriffspunkte. Sie führen über die Aktivierung des Sympathikus und des Renin-Angiotensin-Aldosteron-Systems zu endothelialer Dysfunktion und potenzieren so das Risiko für Herz-Kreislauf-Erkrankungen. Für die Allgemeinbevölkerung ist die Reduktion der kardiovaskulären Mortalität und Morbidität durch nächtliche Maskentherapie mit kontinuierlichem positivem Atemwegsdruck gut belegt, eine Risikoreduktion ist auch für Patienten mit Niereninsuffizienz zu erwarten. Die Verfügbarkeit valider ambulanter Polygraphieverfahren ermöglicht nun eine einfachere Diagnostik. Diskutiert wird, bei welchen Patienten mit Hypertonie und/oder Niereninsuffizienz sich ein Screening empfiehlt. Wird die Diagnose eines Schlafapnoesyndroms gestellt, ist die Überdruckbeatmungsbehandlung die Therapie der Wahl.
Abstract
The prevalence of sleep apnea is significantly increased in patients with all stages of chronic kidney disease. In end-stage renal disease the risk to suffer from obstructive sleep apnea is approximately 4 times higher compared to patients with the same risk factors but healthy kidneys. Renal patients often lack the typical constitution of sleep apnea patients. Furthermore, symptoms, such as daytime sleepiness, are often interpreted as consequences of anemia or uremia. This might explain why sleep apnea is currently underdiagnosed. Sleep apnea and chronic kidney disease potentiate the cardiovascular risk by targeting the same important systems, such as sympathetic nerve activity or the renin-angiotensin-aldosterone cascade. Continuous positive airway pressure therapy is the treatment of choice. There is a growing body of evidence that therapy of sleep apnea leads to a significant reduction of the cardiovascular risk in patients with normal kidney function. Looking at the pathomechanism it can be assumed that renal patients also benefit from therapy of sleep-related disorders. Therefore, validated out-patient screening devices should be used to identify renal patients at risk and initiate early treatment.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11560-009-0340-6/MediaObjects/11560_2009_340_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11560-009-0340-6/MediaObjects/11560_2009_340_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11560-009-0340-6/MediaObjects/11560_2009_340_Fig3_HTML.gif)
Literatur
Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93
Sim JJ, Rasgon SA, Kujubu DA et al (2009) Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 135:710–716
Beecroft JM, Hoffstein V, Pierratos A et al (2007) Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J 30:965–971
Kimmel PL, Miller G, Mendelson WB (1989) Sleep apnea syndrome in chronic renal disease. Am J Med 86:308–314
Kuhlmann U, Becker HF, Birkhahn M et al (2000) Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 53:460–466
Gusbeth-Tatomir P, Boisteanu D, Seica A et al (2007) Sleep disorders: a systematic review of an emerging major clinical issue in renal patients. Int Urol Nephrol 39:1217–1226
Unruh ML, Sanders MH, Redline S et al (2006) Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the Sleep Heart Health Study. J Am Soc Nephrol 17:3503–3509
DGSM (2009) S3 Leitlinie: Nicht erholsamer Schlaf. Somnologie 12:4–160
Yumino D, Bradley TD (2008) Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc 5:226–236
Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384
Tanriverdi H, Evrengul H, Kara CO et al (2006) Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 73:741–750
Munoz R, Duran-Cantolla J, Martinez-Vila E et al (2006) Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 37:2317–2321
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
Markou N, Kanakaki M, Myrianthefs P et al (2006) Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 184:43–49
Hanly PJ, Pierratos A (2001) Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344:102–107
Tang SC, Lam B, Ku PP et al (2006) Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 17:2607–2616
Molnar MZ, Szentkiralyi A, Lindner A et al (2007) High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation – association with declining renal function. Nephrol Dial Transplant 22:2686–2692
Beecroft JM, Hoffstein V, Pierratos A et al (2008) Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 23:673–679
Beecroft J, Duffin J, Pierratos A et al (2006) Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 28:151–158
Buchner NJ, Henning BF, Hagele KF et al (2004) Renal function in hypertensive patients with obstructive sleep apnea. Dtsch Med Wochenschr 129:305–309
Fleischmann G, Fillafer G, Matterer H et al (2009) Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant
Wissing KR, Buchner NJ, Stegbauer J, Rump LC (2007) Renal resistance index in patients with obstructive sleep apnea. Dtsch Med Wochenschr 132:1815–1819
Smith I, Lasserson TJ, Wright J (2006) Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev CD003002
Topfer V, El-Sebai M, Wessendorf TE et al (2004) Adaptive servoventilation: effect on Cheyne-Stokes-Respiration and on quality of life. Pneumologie 58:28–32
Perl J, Unruh ML, Chan CT (2006) Sleep disorders in end-stage renal disease: ‚Markers of inadequate dialysis’? Kidney Int 70:1687–1693
Tang SC, Lam B, Lai AS et al (2009) Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol 4:410–418
Beecroft JM, Duffin J, Pierratos A et al (2009) Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis. Sleep Med 10:47–54
Langevin B, Fouque D, Leger P, Robert D (1993) Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 103:1330–1335
Auckley DH, Schmidt-Nowara W, Brown LK (1999) Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis 34:739–744
Jurado-Gamez B, Martin-Malo A, Rodriguez-Benot A et al (2008) Kidney transplantation improves sleep-related breathing in hemodialysis patients. Blood Purif 26:485–490
Beecroft JM, Zaltzman J, Prasad R et al (2007) Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 22:3028–3033
Grotz W, Buchner N, Wessendorf T et al (2006) Sleep apnea – treatment improves hypertension. Med Klin (Munich) 101:880–885
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quack, I., Fritz, A. & Rump, L. Schlafapnoesyndrom bei chronischer Niereninsuffizienz. Nephrologe 5, 43–48 (2010). https://doi.org/10.1007/s11560-009-0340-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-009-0340-6
Schlüsselwörter
- Schlafbezogene Atmungsstörungen
- Obstruktive Schlafapnoe
- Chronische Niereninsuffizienz
- Dialyse
- Kardiovaskuläres Risiko